Medico Remedies Ltd. (MEDICO) Stock Price & Analysis

0 Followers

MEDICO Stock Chart & Stats

₹18.87-₹0.12(-0.63%)

At close: Nov 11 3:30 PM GMT+5:30

Day’s Range: INR 18.25 - INR 19.39
52-Week Range: INR 17.92 - INR 56.99
Previous Close: INR 18.99
Volume: N/A
Average Volume (3M): 15.53K
Market Cap: INR 1.58B
Enterprise Value: INR 2.06B
Total Cash (Recent Filing): INR 37.51M
Total Debt (Recent Filing): INR 0
Price to Earnings (P/E): 11.5
Beta: 0.20
Next Earnings: Feb 11, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Consistent Revenue Growth

Sustained revenue growth, including acceleration to roughly 20% in FY2026, indicates continued expansion in the company’s pharmaceutical business. If maintained, this stronger top-line trajectory can support operating scale, fund investment, and provide a durable base for future earnings growth.

Healthy Balance Sheet

Steady equity compounding gives Medico Remedies a stronger capital base to support asset growth and absorb business volatility. Manageable leverage also preserves financial flexibility for operations and investment, although the recent increase in borrowings should continue to be monitored.

Improving Profitability

The large increase in net income, alongside consistently strong returns on equity, shows that the company has been converting its expanding capital base into shareholder earnings. This combination supports durable profitability, provided the recent margin volatility does not persist.

Bears Say

Weak Cash Conversion

Operating cash flow declined sharply despite higher net income, while free cash flow became negative after being positive in FY2025. This mismatch weakens earnings quality and may reduce internally generated funding for growth, making reliable cash conversion an important medium-term risk.

Margin Volatility

Unstable gross and operating margins make it harder to assess how much of the company’s revenue growth will translate into durable earnings. Continued margin variability could limit operating leverage and leave profitability more exposed to changes in the business mix or cost structure.

Recent Borrowing Increase

The renewed increase in total debt introduces a higher financial commitment as the company expands. Although leverage has generally been manageable, additional borrowing can reduce flexibility and increase the importance of maintaining sufficient operating cash flow to support investment and obligations.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of dispatching notices for its 31st Annual General Meeting, along with the Annual

1y ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹17.92 and its highest was ₹56.99 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹1.58B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Medico Remedies Ltd.’s earnings last quarter?

Medico Remedies Ltd. released its earnings results on Nov 09, 2026. The company reported ₹0.287 earnings per share for the quarter.

Is Medico Remedies Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Medico Remedies Ltd. reported an EPS of ₹0.287 in its last earnings report. Following the earnings report the stock price went up 5.383%.

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description